HSA-estimated femoral narrow neck cross-sectional area and moment of inertia and outer diameter increased with ibandronate vs. placebo ( respectively 3.6 % , P = 0.003 ; 4.0 % , P = 0.052 ; 2.2 % , P = 0.049 ) .
